Back

Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020

Mizumoto, K.; Chowell, G.

2020-02-23 infectious diseases
10.1101/2020.02.19.20025163 medRxiv
Show abstract

Since the first case of Novel Coronavirus (2019-nCov) was identified in December 2019 in Wuhan City, China, the number of cases continues to grow across China and multiple cases have been exported to other countries. The cumulative number of reported deaths is at 637 as of February 7, 2020. Here we statistically estimated the time-delay adjusted death risk for Wuhan as well as for China excluding Wuhan to interpret the current severity of the epidemic in China. We found that the latest estimates of the death risk in Wuhan could be as high as 20% in the epicenter of the epidemic whereas we estimate it [~]1% in the relatively mildly-affected areas. Because the elevated death risk estimates are likely associated with a breakdown of the medical/health system, enhanced public health interventions including social distancing and movement restrictions should be effectively implemented to bring the epidemic under control.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
The Innovation
13 papers in training set
Top 0.1%
18.7%
2
International Journal of Infectious Diseases
129 papers in training set
Top 0.1%
12.0%
3
Scientific Reports
3612 papers in training set
Top 15%
5.6%
4
Nature Communications
5641 papers in training set
Top 27%
5.5%
5
PLOS ONE
5266 papers in training set
Top 32%
4.4%
6
The Lancet Infectious Diseases
73 papers in training set
Top 0.3%
4.1%
50% of probability mass above
7
Cell Discovery
57 papers in training set
Top 0.2%
3.5%
8
Virologica Sinica
11 papers in training set
Top 0.1%
2.4%
9
Science China Life Sciences
29 papers in training set
Top 0.2%
2.1%
10
Clinical Infectious Diseases
235 papers in training set
Top 1%
2.1%
11
The Journal of Infectious Diseases
202 papers in training set
Top 2%
1.9%
12
Frontiers in Public Health
148 papers in training set
Top 3%
1.9%
13
Signal Transduction and Targeted Therapy
30 papers in training set
Top 0.3%
1.7%
14
Emerging Infectious Diseases
105 papers in training set
Top 0.9%
1.7%
15
Influenza and Other Respiratory Viruses
46 papers in training set
Top 0.5%
1.4%
16
Journal of Medical Virology
140 papers in training set
Top 2%
1.1%
17
Frontiers in Physics
21 papers in training set
Top 0.2%
1.1%
18
eLife
5828 papers in training set
Top 60%
1.1%
19
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 37%
1.0%
20
PeerJ
308 papers in training set
Top 10%
1.0%
21
Science Advances
1243 papers in training set
Top 30%
0.9%
22
Journal of Biomedical Science
17 papers in training set
Top 0.3%
0.9%
23
Journal of Clinical Medicine
97 papers in training set
Top 5%
0.9%
24
Virology Journal
32 papers in training set
Top 0.8%
0.9%
25
Vaccines
198 papers in training set
Top 3%
0.9%
26
Epidemics
116 papers in training set
Top 2%
0.9%
27
JAMA Network Open
130 papers in training set
Top 4%
0.9%
28
Annals of Translational Medicine
18 papers in training set
Top 0.6%
0.9%
29
BMC Medicine
176 papers in training set
Top 6%
0.6%
30
Frontiers in Genetics
230 papers in training set
Top 6%
0.6%